SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-23-003251
Filing Date
2023-02-01
Accepted
2023-02-01 09:00:20
Documents
12
Period of Report
2023-02-01
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 46120
  Complete submission text file 0001493152-23-003251.txt   222860

Data Files

Seq Description Document Type Size
2 INLINE XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT xtnt-20230201.xsd EX-101.SCH 3239
3 INLINE XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT xtnt-20230201_lab.xml EX-101.LAB 34916
4 INLINE XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT xtnt-20230201_pre.xml EX-101.PRE 22797
6 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3704
Mailing Address 664 CRUISER LANE BELGRADE MT 59714
Business Address 664 CRUISER LANE BELGRADE MT 59714 406-388-0480
Xtant Medical Holdings, Inc. (Filer) CIK: 0001453593 (see all company filings)

IRS No.: 205313323 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-34951 | Film No.: 23574877
SIC: 2836 Biological Products, (No Diagnostic Substances)